{"filing":{"accession_number":"0001193125-26-281969","cik":"0001585608","ticker":"JAGX","company_name":"Jaguar Health, Inc.","form":"8-K","filing_date":"2026-06-25","report_date":null,"primary_document":"d110630d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1585608/000119312526281969/d110630d8k.htm"},"events":[{"id":13771,"run_id":12234,"accession_number":"0001193125-26-281969","anchor_item_number":"1.01","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.72,"summary":"Jaguar Health executed the First Amendment to its Manufacturing and Supply Agreement with Woodward Specialty LLC, clarifying inventory management and title transfer procedures during an operational transition period through December 31, 2026.","company_name":"Jaguar Health, Inc.","ticker":"JAGX","filing_date":"2026-06-25","form":"8-K","submitted_at":null,"items":[{"id":11007,"accession_number":"0001193125-26-281969","item_number":"1.01","item_title":null,"event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.72,"reasoning":"The First Amendment to the Manufacturing and Supply Agreement with Woodward Specialty LLC clarifies inventory management and title transfer procedures during an operational transition period through December 31, 2026. While this is a material definitive agreement amendment affecting the company's supply chain and manufacturing operations, it does not fit the specific categories of M\u0026A activity, debt issuance, or other named financial/legal events. The amendment is primarily operational in nature, addressing business continuity during Woodward's licensing transitions, making it an operational event that does not fit a more specific category.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-25T13:16:40.251737+00:00","company_name":"","ticker":null,"filing_date":""}]},{"id":13772,"run_id":12234,"accession_number":"0001193125-26-281969","anchor_item_number":"8.01","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"summary":"The Company exercised its right to convert Series O Convertible Preferred Stock into common stock at a conversion ratio of 3.209 shares per preferred share, resulting in a material dilutive issuance of common stock that increases outstanding share count and dilutes existing common shareholders.","company_name":"Jaguar Health, Inc.","ticker":"JAGX","filing_date":"2026-06-25","form":"8-K","submitted_at":null,"items":[{"id":11008,"accession_number":"0001193125-26-281969","item_number":"8.01","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"The Company exercised its right to convert Series O Convertible Preferred Stock into common stock at a conversion ratio of 3.209 shares per preferred share. This mandatory conversion of preferred stock into common stock is a dilutive capital event that increases the outstanding share count and dilutes existing common shareholders. While the preferred stock was issued as a special dividend in February 2026, the conversion itself represents a material dilutive issuance of common stock that would affect investor assessment of ownership and voting power.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-25T13:16:40.251737+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":11007,"accession_number":"0001193125-26-281969","item_number":"1.01","item_title":null,"event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.72,"reasoning":"The First Amendment to the Manufacturing and Supply Agreement with Woodward Specialty LLC clarifies inventory management and title transfer procedures during an operational transition period through December 31, 2026. While this is a material definitive agreement amendment affecting the company's supply chain and manufacturing operations, it does not fit the specific categories of M\u0026A activity, debt issuance, or other named financial/legal events. The amendment is primarily operational in nature, addressing business continuity during Woodward's licensing transitions, making it an operational event that does not fit a more specific category.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-25T13:16:40.251737+00:00","company_name":"Jaguar Health, Inc.","ticker":"JAGX","filing_date":"2026-06-25"},{"id":11008,"accession_number":"0001193125-26-281969","item_number":"8.01","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"The Company exercised its right to convert Series O Convertible Preferred Stock into common stock at a conversion ratio of 3.209 shares per preferred share. This mandatory conversion of preferred stock into common stock is a dilutive capital event that increases the outstanding share count and dilutes existing common shareholders. While the preferred stock was issued as a special dividend in February 2026, the conversion itself represents a material dilutive issuance of common stock that would affect investor assessment of ownership and voting power.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-25T13:16:40.251737+00:00","company_name":"Jaguar Health, Inc.","ticker":"JAGX","filing_date":"2026-06-25"}]}